Published in Invest Radiol on May 01, 2012
Diffusion weighted magnetic resonance imaging of the breast: protocol optimization, interpretation, and clinical applications. Magn Reson Imaging Clin N Am (2013) 0.91
Diffusion tensor magnetic resonance imaging of the pancreas. PLoS One (2014) 0.86
Multiparametric MR Imaging of Breast Cancer. Magn Reson Imaging Clin N Am (2016) 0.86
MR scanner systems should be adequately characterized in diffusion-MRI of the breast. PLoS One (2014) 0.84
Quantitative breast MRI: 2D histogram analysis of diffusion tensor parameters in normal tissue. MAGMA (2013) 0.81
Microstructural models for diffusion MRI in breast cancer and surrounding stroma: an ex vivo study. NMR Biomed (2016) 0.78
Diffusion-tensor imaging as an adjunct to dynamic contrast-enhanced MRI for improved accuracy of differential diagnosis between breast ductal carcinoma in situ and invasive breast carcinoma. Chin J Cancer Res (2015) 0.78
Assessing Detection, Discrimination, and Risk of Breast Cancer According to Anisotropy Parameters of Diffusion Tensor Imaging. Med Sci Monit (2016) 0.76
Tracking the mammary architectural features and detecting breast cancer with magnetic resonance diffusion tensor imaging. J Vis Exp (2014) 0.76
Diffusion tensor imaging of breast lesions: evaluation of apparent diffusion coefficient and fractional anisotropy and tissue cellularity. Br J Radiol (2016) 0.76
The Changing World of Breast Cancer: A Radiologist's Perspective. Invest Radiol (2015) 0.75
Diffusion tensor imaging in the normal breast: influences of fibroglandular tissue composition and background parenchymal enhancement. Clin Imaging (2015) 0.75
Clinical Breast MR Using MRS or DWI: Who Is the Winner? Front Oncol (2016) 0.75
Diffusion-weighted breast MRI: Clinical applications and emerging techniques. J Magn Reson Imaging (2016) 0.75
Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients. Clin Cancer Res (2010) 3.02
Diabetes mellitus and breast cancer. Lancet Oncol (2005) 2.34
MRI guidance of focused ultrasound therapy of uterine fibroids: early results. AJR Am J Roentgenol (2004) 2.19
Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population. Proc Natl Acad Sci U S A (2006) 1.99
Kinetics of hyperpolarized 13C1-pyruvate transport and metabolism in living human breast cancer cells. Proc Natl Acad Sci U S A (2009) 1.93
Pain palliation in patients with bone metastases using MR-guided focused ultrasound surgery: a multicenter study. Ann Surg Oncol (2008) 1.85
Phosphocholine as a biomarker of breast cancer: molecular and biochemical studies. Int J Cancer (2007) 1.72
Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging--initial results. Radiology (2007) 1.67
Triple-negative breast cancer: present challenges and new perspectives. Mol Oncol (2010) 1.63
Coronary calcium by spiral computed tomography predicts cardiovascular events in high-risk hypertensive patients. J Hypertens (2004) 1.57
Water diffusion in the different microenvironments of breast cancer. NMR Biomed (2004) 1.40
Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis. Cancer Res (2002) 1.40
Adjuvant chemotherapy and whole abdominal irradiation for gastric carcinoma. Tumori (2008) 1.39
Haplotype structure and selection of the MDM2 oncogene in humans. Proc Natl Acad Sci U S A (2007) 1.28
CT findings in patients with small bowel obstruction due to phytobezoar. Emerg Radiol (2003) 1.28
Mutant KRAS is a druggable target for pancreatic cancer. Proc Natl Acad Sci U S A (2013) 1.26
A phase II study of Imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands. Oral Oncol (2006) 1.26
Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients. J Immunother (2009) 1.25
Magnetic resonance imaging reveals functional diversity of the vasculature in benign and malignant breast lesions. Cancer (2005) 1.23
Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic peptide. Cancer Res (2006) 1.18
Model-based and model-free parametric analysis of breast dynamic-contrast-enhanced MRI. NMR Biomed (2009) 1.18
Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients. Cancer (2006) 1.13
Neoadjuvant imatinib for unresectable gastrointestinal stromal tumor. Anticancer Drugs (2004) 1.10
Principal component analysis of breast DCE-MRI adjusted with a model-based method. J Magn Reson Imaging (2009) 1.08
Hormonal regulation of VEGF in orthotopic MCF7 human breast cancer. Cancer Res (2002) 1.07
Clinical testing of high-spatial-resolution parametric contrast-enhanced MR imaging of the breast. AJR Am J Roentgenol (2002) 1.07
Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: a pilot study. Acad Radiol (2007) 1.07
Coronary calcification compared in patients with acute versus in those with chronic coronary events by using dual-sector spiral CT. Radiology (2003) 1.06
Real-time imaging of lymphogenic metastasis in orthotopic human breast cancer. Cancer Res (2006) 1.04
Association between diabetes mellitus and adverse characteristics of breast cancer at presentation. Eur J Cancer (2006) 1.04
Parametric analysis of breast MRI. J Comput Assist Tomogr (2002) 1.03
Glycolysis and glucose transporter 1 as markers of response to hormonal therapy in breast cancer. Int J Cancer (2003) 1.00
Strains and stresses in sub-dermal tissues of the buttocks are greater in paraplegics than in healthy during sitting. J Biomech (2007) 0.96
Glycolysis as a metabolic marker in orthotopic breast cancer, monitored by in vivo (13)C MRS. Am J Physiol Endocrinol Metab (2002) 0.95
Principal component analysis of dynamic contrast enhanced MRI in human prostate cancer. Invest Radiol (2010) 0.95
Functional sodium magnetic resonance imaging of the intact rat kidney. Kidney Int (2004) 0.94
Acute epiploic appendagitis: CT findings in 33 cases. Emerg Radiol (2002) 0.94
Magnetic resonance-guided focused ultrasound surgery for the noninvasive curative ablation of tumors and palliative treatments: a review. Ann Surg Oncol (2007) 0.93
Noninvasive magnetic resonance imaging of transport and interstitial fluid pressure in ectopic human lung tumors. Cancer Res (2006) 0.92
High-resolution magnetic resonance imaging of disparities in the transcapillary transfer rates in orthotopically inoculated invasive breast tumors. Cancer Res (2004) 0.92
Assessment of mechanical conditions in sub-dermal tissues during sitting: a combined experimental-MRI and finite element approach. J Biomech (2006) 0.91
Stromal extracellular matrix reduces chemotherapy-induced apoptosis in colon cancer cell lines. Clin Exp Metastasis (2002) 0.91
Magnetic resonance-guided focused ultrasound surgery (MRgFUS): ablation of liver tissue in a porcine model. Eur J Radiol (2006) 0.90
Magnetization transfer magic-angle-spinning z-spectroscopy of excised tissues. J Magn Reson (2009) 0.90
Sodium magnetic resonance imaging of diuresis: spatial and kinetic response. Magn Reson Med (2005) 0.88
Water-soluble contrast agents targeted at the estrogen receptor for molecular magnetic resonance imaging. Bioconjug Chem (2007) 0.88
Adjuvant radiotherapy for thymic epithelial tumor: treatment results and prognostic factors. Am J Clin Oncol (2007) 0.87
Structure of estradiol metal chelate and estrogen receptor complex: the basis for designing a new class of selective estrogen receptor modulators. J Med Chem (2011) 0.86
Diffusion-tensor MR imaging of the breast: hormonal regulation. Radiology (2014) 0.86
Sleeve gastrectomy: radiologic patterns after surgery. Surg Endosc (2009) 0.86
In vivo magnetic resonance imaging of the estrogen receptor in an orthotopic model of human breast cancer. Cancer Res (2011) 0.85
Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: the role of estrogen receptor alpha and c-Myc. Endocr Relat Cancer (2009) 0.84
Magnetic resonance imaging of tumor vasculature. Thromb Haemost (2003) 0.84
Concurrent chemobiotherapy with cisplatin, dacarbazine, decrescendo interleukin-2 and interferon alpha2b in patients with metastatic melanoma. Oncol Rep (2008) 0.84
A phase II study of oral UFT and leucovorin concurrently with pelvic irradiation as neoadjuvant chemoradiation for rectal cancer. Anticancer Res (2007) 0.83
Non-invasive imaging of barriers to drug delivery in tumors. Microvasc Res (2008) 0.83
Syringomatous adenoma of the nipple: a case report. Pathol Res Pract (2005) 0.83
Magnetic resonance-guided focused ultrasound surgery (MRgFUS). Four ablation treatments of a single canine hepatocellular adenoma. HPB (Oxford) (2006) 0.83
Coronary artery calcium measurement with multi-detector row CT and low radiation dose: comparison between 55 and 165 mAs. Radiology (2005) 0.83
A single Mediterranean, possibly Jewish, origin for the Val59Gly CDKN2A mutation in four melanoma-prone families. Eur J Hum Genet (2003) 0.82
Radiation rescue for biochemical failure after surgery for prostate cancer: predictive parameters and an assessment of contemporary predictive models. Am J Clin Oncol (2006) 0.81
Vascular perfusion of human lung cancer in a rat orthotopic model using dynamic contrast-enhanced magnetic resonance imaging. Int J Cancer (2006) 0.81
Hormone receptor expression is associated with a unique pattern of metastatic spread and increased survival among HER2-overexpressing breast cancer patients. Am J Clin Oncol (2009) 0.81
The management of cancer pain in the elderly. Crit Rev Oncol Hematol (2009) 0.81
Parametric imaging of tumor perfusion using flow- and permeability-limited tracers. J Magn Reson Imaging (2002) 0.80
Association between very young age and adverse characteristics of breast cancer at presentation amongst Israeli women. Am J Clin Oncol (2011) 0.80
Choline in the aging brain. Brain Res (2002) 0.79
Adoptive cell therapy for metastatic melanoma patients: pre-clinical development at the Sheba Medical Center. Isr Med Assoc J (2006) 0.79
High incidence of fistula formation during bevacizumab treatment in rectal cancer patients. Acta Oncol (2007) 0.78
Characterization of estrogen-receptor-targeted contrast agents in solution, breast cancer cells, and tumors in vivo. Magn Reson Med (2012) 0.78
Advantages and drawbacks of breast DTI. Eur J Radiol (2012) 0.78
[Body weight, nutritional factors and physical activity--their influence on prognosis after breast cancer diagnosis]. Harefuah (2006) 0.78
Direct detection of brain acetylcholine synthesis by magnetic resonance spectroscopy. Brain Res (2005) 0.78
[Three-dimensional conformal radiation therapy concurrent with full dose Gemcitabine for locally advanced inoperable pancreatic cancer]. Harefuah (2008) 0.78
The founder Ashkenazi Jewish mutations in the MSH2 and MSH6 genes in Israeli patients with gastric and pancreatic cancer. Fam Cancer (2012) 0.78
Postoperative swallow study as a predictor of intermediate weight loss after sleeve gastrectomy. Obes Surg (2013) 0.77
Combined jugular and subclavian vein thrombosis following assisted reproductive technology--new observation. Fertil Steril (2008) 0.77
In vivo magnetic resonance of hyperpolarized [(13)C1]pyruvate: metabolic dynamics in stimulated muscle. Am J Physiol Endocrinol Metab (2013) 0.77
Incisional endometriomas: CT findings. Emerg Radiol (2005) 0.77
Salvage prostatic fossa radiation therapy for biochemical failure after radical prostatectomy: the Sheba experience. Isr Med Assoc J (2004) 0.77